Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat

Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.

Investors Business Daily

Pfizer Stock Recovers, But Covid Products Drive 41% Sales Decline, Losses

Pfizer stock closed flat Tuesday after its sales missed third-quarter sales forecasts and on mixed results for its messenger RNA-based flu shot.

Investors Business Daily

Dow Jones Falls 125 Points After Key Housing Data; Caterpillar Dives On Earnings

The Dow Jones Industrial Average dropped 125 points Tuesday after key housing data. Tesla stock continued to slide after Monday's dive.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

COVID-19 treatments to enter the market with a hefty price tag

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

The Independent UK

On 2023’s 100 Fastest-Growing Companies list, Tesla makes its debut and energy companies take off

Tesla was one of several industrial companies in the top five, while Pfizer and energy giants Chevron and ExxonMobil also put up big numbers.

Fortune

Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout

Roche said Monday it would buy an experimental immunology drug from Roivant and Pfizer for $7.1 billion. But ROIV stock sank.

Investors Business Daily

Pfizer and KIMS Hospital launch Center of Excellence for adult vaccination

Pfizer & KIMS Hospital in Hyderabad inaugurated a CoE for Adult Vaccination to equip HCPs & educate patients on enduring advantages of vaccinations. It will reinforce immunisation against Pneumococcal, Hepatitis A/B, HPV & Influenza. CoE symbolises commitment to protecting individuals against respiratory threats & enhancing quality of life.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Company bosses and workers grapple with the fallout of speaking up about the Israel-Hamas war

The fallout from the Israel-Hamas war has spilled into workplaces everywhere, with corporate leaders from the highest ranks of prominent companies weighing in with their views while workers complain their voices are not being heard

The Independent UK

Pfizer doubling cost of Paxlovid

One of the most effective treatments for COVID is going to get a lot more expensive, but Pfizer insists it's fine

Salon

Pfizer Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid

Pfizer is hiking its Paxlovid price to $1,390 for a five-day course of the Covid pill. But Pfizer stock fell early Thursday.

Investors Business Daily

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

Barchart

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The Conversation

Stock Market Remains Steadfast; Data Analytics Stock Pops On Upgrade

The stock market remained positive with the major indexes all gaining around 1%. Retail stock rises on news it will get added to the S&P 500 Index.

Investors Business Daily

Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion

Moderna stock and BioNTech stock led a sell-off Monday among Covid vaccine makers after Pfizer slashed its full-year guidance.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products

Shares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products

Fortune

Pfizer CEO Albert Bourla wants to tap 'Chinese science' as the drug company looks for a new target after COVID

Bourla hopes to bring the same speed in developing a COVID vaccine to discovering new cancer treatments.

Fortune

Modern companies need a purpose. Execs share advice

“It’s so incredibly powerful [to] have a very clear sense of your objectives.” Angela Hwang, Pfizer’s chief commercial officer said during a MPW panel.

Sports Illustrated

Minneapolis Radio Station Trolls Taylor Swift, Travis Kelce With Billboard Before Chiefs-Vikings

Minnesota knew what audience to tailor to, no pun intended.

Get all your
news in one place.

100’s of premium titles.
One news app.

Sports Illustrated

Chiefs’ Travis Kelce Responds to Aaron Rodgers’s ‘Mr. Pfizer’ Jab

“Who knew I’d get into the vax wars with Aaron Rodgers, man?”

The Texas Tribune

Updated COVID-19 shot slowly rolls out in Texas, but access is spotty

Doses aren’t arriving at providers’ offices at uniform, predictable intervals. Shipments are largely dependent on individual providers’ ability to work out the logistics of ordering, stocking, training and paperwork.

Zenger

Travis Kelce’s Rumored Romance With Taylor Swift Boosts Brand Engagement

Pfizer and Campbell Soup see surge in searches and sales after dating rumors

StockNews.com

Which Pharma Stock Has More Potential Gains This Month: Pfizer (PFE) or Eli Lilly & Co. (LLY)?

The pharmaceutical industry is poised for sustained long-term growth due to increased investments in drug development and rapid technological advancements. While leading pharma stocks Pfizer (PFE) and Eli Lilly (LLY) stand to benefit, let us analyze which of these giants is poised for more gains this month. Keep reading.

Salon

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Barchart

3 Quality Stocks to Defend Your Portfolio Against October Volatility

The sell-off in the U.S. stock market has deepened in October, and the Dow Jones Industrial Average is now negative for the year. Amid a challenging macro environment, Berkshire Hathaway, Pfizer, and Coca-Cola look like three good defensive stocks to buy.

Investors Business Daily

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna

The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.